BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
Data as of , from SEC Form 4 filings.
See up to 3 months of BCLI. The 7-day demo opens the 1M and 3M ranges and puts BCLI on your watchlist.
Start 7-day demoLatest BCLI insider trades
About BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BCLI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 1,000,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BCLI insider transactions (Form 4)
1514 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock | 100,000 footnote F1 | $0.00 | - | ||
| ||||||
| Peter Joe Pitts - Officer | Grant or award | Stock Option (Right to Buy) | 900,000 | $0.00 | - | |
| Chaim Lebovits - Officer | Grant or award | Common Stock | 1,800,000 footnote F1 | $0.00 | - | |
| ||||||
| Uri Yablonka - Officer | Grant or award | Common Stock | 150,000 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 100,000 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 200,000 footnote F1 | $0.00 | - | ||
| ||||||
| Irit Arbel - Director | Grant or award | Common Stock | 120,000 footnote F1 | $0.00 | - | |
| ||||||
| Menghisteab Bairu - Director | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.70 footnote F1 | $105K | |
| ||||||
| Anthony J. Polverino - Director | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.70 footnote F1 | $105K | |
| ||||||
| Hartoun Hartounian - Director | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.70 footnote F1 | $158K | |
| ||||||
| Stacy Lindborg - Director | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.70 footnote F1 | $105K | |
| ||||||
| Grant or award | Stock Option (Right to Buy) | 180,000 | $0.70 footnote F1 | $126K | ||
| ||||||
| Grant or award | Stock Option (Right to Buy) | 225,000 | $0.70 footnote F1 | $158K | ||
| ||||||
| Chaim Lebovits - Officer | Open-market purchase | Common Stock | 22,000 | $3.42 | $5K | |
| Chaim Lebovits - Officer | Open-market purchase | Common Stock | 1,836 | $3.43 | $6K | |
BCLI insider trading FAQ
What is the latest insider trade for BCLI?
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had 2 insider filings in the last 90 days, with the most recent on 2026-07-28. The full record for BCLI runs to 14 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BCLI stock?
No insider purchases of BCLI were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling BCLI stock?
No insider sales of BCLI were filed in the last 90 days.
Where can I see BCLI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BCLI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jacob A. Frenkel view on EDGAR
- - Peter Joe Pitts view on EDGAR
- - Chaim Lebovits view on EDGAR
- - Uri Yablonka view on EDGAR
- - Alla Patlis view on EDGAR
- - Jacob A. Frenkel view on EDGAR
- - Irit Arbel view on EDGAR
- - Menghisteab Bairu view on EDGAR
- - Anthony J. Polverino view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BCLI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BCLI with a 7-day demo
- BCLI on your watchlist
- Every BCLI Form 4 filing on record
- Up to 3 months of BCLI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive